CHRM3 is a novel prognostic factor of poor prognosis in patients with endometrial carcinoma.

PubWeight™: 0.81‹?›

🔗 View Article (PMC 4494141)

Published in Am J Transl Res on May 15, 2015

Authors

Yahui Wang1, Jun Li2, Shanyun Wen3, Xiaomei Yang2, Yanli Zhang2, Zhijie Wang4, Zhigang Zhang2

Author Affiliations

1: Department of Gynecology and Obstetrics, Shanghai Eighth People Hospital, Jiangsu University Shanghai, P.R. China ; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai, P.R. China.
2: State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai, P.R. China.
3: Department of Obstetrics and Gynecology, Shanghai Songjiang District Central Hospital Shanghai, P.R. China.
4: Department of Gynecology and Obstetrics, Shanghai Eighth People Hospital, Jiangsu University Shanghai, P.R. China.

Articles cited by this

Cancer statistics, 2014. CA Cancer J Clin (2014) 72.81

Identification of a family of muscarinic acetylcholine receptor genes. Science (1987) 6.21

Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptor. Nature (1986) 4.97

Muscarinic receptors and ligands in cancer. Am J Physiol Cell Physiol (2008) 1.42

M3 muscarinic receptor antagonists inhibit small cell lung carcinoma growth and mitogen-activated protein kinase phosphorylation induced by acetylcholine secretion. Cancer Res (2007) 1.23

Acetylcholine-induced activation of M3 muscarinic receptors stimulates robust matrix metalloproteinase gene expression in human colon cancer cells. Am J Physiol Gastrointest Liver Physiol (2009) 1.19

Sympathetic and parasympathetic regulation of the uterine blood flow and contraction in the rat. J Auton Nerv Syst (1996) 1.07

Muscarinic receptor subtypes involved in carbachol-induced contraction of mouse uterine smooth muscle. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.95

Pharmacological evidence for distinct muscarinic receptor subtypes coupled to the inhibition of adenylate cyclase and to the increased generation of inositol phosphates in the guinea pig myometrium. J Pharmacol Exp Ther (1990) 0.93

Functional muscarinic m3 receptor expressed in gastric cancer cells stimulates tyrosine phosphorylation and MAP kinase. J Gastroenterol (1999) 0.90

Regional and muscle layer variations in cholinergic nerve control of the rat myometrium during the oestrous cycle. Auton Neurosci (2003) 0.88

Overexpression of muscarinic receptor 3 promotes metastasis and predicts poor prognosis in non-small-cell lung cancer. J Thorac Oncol (2014) 0.87

PNMA1 promotes cell growth in human pancreatic ductal adenocarcinoma. Int J Clin Exp Pathol (2014) 0.87

Effect of estrogen on muscarinic acetylcholine receptor expression in rat myometrium. Mol Cell Endocrinol (2004) 0.85

Characterization of the muscarinic receptor subtype that mediates the contractile response of acetylcholine in the swine myometrium. Eur J Pharmacol (1999) 0.85

Activation of muscarinic cholinergic receptors induces MCF-7 cells proliferation and angiogenesis by stimulating nitric oxide synthase activity. Cancer Biol Ther (2007) 0.85

Calcitonin gene-related peptide in the rat uterus: presence in nerves and effects on uterine contraction. Peptides (1990) 0.84

High expression of M3 muscarinic acetylcholine receptor is a novel biomarker of poor prognostic in patients with non-small cell lung cancer. Tumour Biol (2013) 0.82

Responses to catecholamines of the rat isolated uterus throughout the natural oestrous cycle. Naunyn Schmiedebergs Arch Pharmacol (1982) 0.78